Spots Global Cancer Trial Database for lymphoma, malignant
Every month we try and update this database with for lymphoma, malignant cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors | NCT02440685 | Lymphoma, Large... Lymphoma, Mantl... Lymphoma, Folli... Cancer Neoplasm Tumor Lymphoma, Malig... Lymphoma, B-cel... Lymphoma, Non-H... B-Cell Chronic ... B-Cell Leukemia... B-Lymphocytic L... Chronic Lymphoc... Leukemia, Lymph... Leukemia, Lymph... Myelofibrosis Chronic Idiopat... Idiopathic Myel... Lymphoma, T Cel... Peripheral T-Ce... T-Cell Lymphoma... | ASN002 Dose Esc... ASN002 RD | 18 Years - | Asana BioSciences | |
| Dosing and Safety Study of E7820 in Patients With a Malignant Solid Tumor or Lymphoma | NCT00078637 | Neoplasms Lymphoma, Malig... | E7820 | 18 Years - | Eisai Inc. | |
| Efficacy of Patient Management for Lymphoma Diagnosed at Nimes University Hospital From 1999 to 2018. DVR-Lym-Nim | NCT04947618 | Lymphoma, Malig... | 15 Years - | Centre Hospitalier Universitaire de Nīmes | ||
| DS-3201b in Participants With Lymphomas | NCT02732275 | Lymphoma, Malig... Non-hodgkin Lym... | DS-3201b | 18 Years - | Daiichi Sankyo | |
| Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood | NCT00146055 | Myeloma, Plasma... Lymphoma, Malig... Myeloproliferat... Myelodysplastic... Waldenstrom's M... | Reduced intensi... | - | University of Michigan Rogel Cancer Center | |
| A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin | NCT01388335 | Solid Tumor Lymphoma, Malig... | warfarin enzastaurin | 18 Years - 60 Years | Eli Lilly and Company | |
| Open-Label, Non Randomized Phase 2 Study With Safety Run-In | NCT02249429 | Lymphoma, Malig... | bimiralisib | 18 Years - | PIQUR Therapeutics AG | |
| Myeloid-Derived Suppressor Cells and Checkpoint Immune Regulators' Expression in Allogeneic SCT Using FluBuATG | NCT02916979 | Leukemia, Lymph... Leukemia, Myelo... Myelodysplastic... Myelofibrosis Lymphoma, Malig... Multiple Myelom... Waldenstrom Mac... | Fludarabine Busulfan Rabbit ATG Methotrexate | 18 Years - 75 Years | Dartmouth-Hitchcock Medical Center | |
| A Drug Interaction Study to Assess the Effect of LY317615 on the Metabolic Pathway of Warfarin | NCT01388335 | Solid Tumor Lymphoma, Malig... | warfarin enzastaurin | 18 Years - 60 Years | Eli Lilly and Company | |
| Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma | NCT00509184 | Lymphoma, Malig... | Rituximab | 18 Years - 75 Years | Heidelberg University | |
| DS-3201b in Participants With Lymphomas | NCT02732275 | Lymphoma, Malig... Non-hodgkin Lym... | DS-3201b | 18 Years - | Daiichi Sankyo | |
| Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood | NCT00146055 | Myeloma, Plasma... Lymphoma, Malig... Myeloproliferat... Myelodysplastic... Waldenstrom's M... | Reduced intensi... | - | University of Michigan Rogel Cancer Center | |
| Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood | NCT00146055 | Myeloma, Plasma... Lymphoma, Malig... Myeloproliferat... Myelodysplastic... Waldenstrom's M... | Reduced intensi... | - | University of Michigan Rogel Cancer Center | |
| A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma | NCT01432951 | Solid Tumor Lymphoma, Malig... | Enzastaurin | 18 Years - | Eli Lilly and Company | |
| A Study of Enzastaurin in Chinese Patients With Advanced and/or Metastatic Solid Tumors or Lymphoma | NCT01432951 | Solid Tumor Lymphoma, Malig... | Enzastaurin | 18 Years - | Eli Lilly and Company | |
| DS-3201b in Participants With Lymphomas | NCT02732275 | Lymphoma, Malig... Non-hodgkin Lym... | DS-3201b | 18 Years - | Daiichi Sankyo | |
| Myeloablative Hematopoietic Progenitor Cell Transplantation (HPCT) for Pediatric Malignancies | NCT00619879 | Leukemia, Myelo... Leukemia, Lymph... Leukemia, Myelo... Myeloproliferat... Lymphoma, Malig... | Myeloablative C... Myeloablative C... Hematopoietic P... CNS radiation t... | - 21 Years | Ann & Robert H Lurie Children's Hospital of Chicago | |
| Low-Intensity Preparation and Allogeneic Transplant in Patients With Cancers of the Blood | NCT00146055 | Myeloma, Plasma... Lymphoma, Malig... Myeloproliferat... Myelodysplastic... Waldenstrom's M... | Reduced intensi... | - | University of Michigan Rogel Cancer Center | |
| Open-Label, Non Randomized Phase 2 Study With Safety Run-In | NCT02249429 | Lymphoma, Malig... | bimiralisib | 18 Years - | PIQUR Therapeutics AG | |
| Multi-day Doses in Prevention of Nausea and Emesis | NCT00600353 | Myeloma, Plasma... Lymphoma, Malig... | Palonosetron Aprepitant Dexamethasone | 18 Years - | University of Kansas Medical Center | |
| A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies | NCT00741871 | Lymphoma, Malig... Hodgkin's Lymph... B Cell Lymphoma | SB1518 | 18 Years - | S*BIO |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
